| Jun 24 |
Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
|
| Jun 14 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
|
| Jun 13 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
|
| Jun 11 |
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
|
| Jun 11 |
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
|
| Jun 10 |
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
|
| Jun 7 |
Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
|
| Jun 7 |
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
|
| May 29 |
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
|
| May 29 |
BMS stakes $80m on Prothena’s neurodegenerative candidate
|
